To establish whether the new nutraceutical formulation was effective in vivo in modulating IL-8 nasal wash levels, an observational prospective study on COPD patients (n = 16), treated or not with the new nutraceutical formulation for 6 months, was conducted. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.